Prices are updated after-hours


Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date

tags : Fda    save search

Altamira Therapeutics Receives FDA 510(k) Clearance for Bentrio to Treat Allergic Rhinitis
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
CYTO | News | $0.5792 13.35% -0.2% | twitter stocktwits trandingview |
Manufacturing
| | O: 22.36% H: 0.0% C: -13.62%

fda clearance for therapeutics
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
CYBN | News | $0.615 4.7% 0.81% | twitter stocktwits trandingview |
n/a
| | O: 0.44% H: 8.47% C: 4.24%

cyb003 treatment fda clearance for trial potential
ADMA BioCenters Receives FDA Approval for its Sixth Plasma Collection Center, Located in Myrtle Beach, SC
Published: 2022-06-27 (Crawled : 12:00) - admabiologics.com
ADMA | News | $2.16 11.34% 1.03% | twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 6.93% C: 6.93%

fda for approval
Nuvation Bio Announces FDA Partial Clinical Hold for Phase 1 Study of NUV-422 in Solid Tumors
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
NUVB | News | $3.64 -13.13% 0.0% | twitter stocktwits trandingview |
| | O: -2.25% H: 0.12% C: -11.97%

nuv-422 fda for
Todays' Top-5
Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery SystemInnovative Transseptal Access System Is First and Only to Feature Integrated Dilator and Needle to Reduce Exchanges
Published: 2022-06-27 (Crawled : 11:00) - biospace.com/
AFIB | News A | $1.015 88.52% 14.82% | twitter stocktwits trandingview |
Health Technology
| | O: 85.93% H: 0.0% C: 0.0%

fda system extension commercial
Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease
Published: 2022-06-27 (Crawled : 08:00) - biospace.com/
ALPMY | News | $16.205 | twitter stocktwits trandingview |
Manufacturing
| | O: -1.2% H: 0.0% C: -0.37%

at845 fda disease trial update
Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease
Published: 2022-06-26 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $16.205 | twitter stocktwits trandingview |
Manufacturing
| | O: -1.2% H: 0.0% C: -0.37%

at845 fda disease trial update
Cytokinetics Announces Date for FDA Advisory Committee Meeting to Review New Drug Application for Omecamtiv Mecarbil
Published: 2022-06-24 (Crawled : 12:00) - globenewswire.com
CYTK | $48.93 3.56% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 9.47% H: 0.25% C: -1.52%

fda drug for meeting application review
Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
Published: 2022-06-24 (Crawled : 11:00) - globenewswire.com
EBS | $32.65 -0.34% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 6.55% H: 0.91% C: -0.27%

av7909 fda candidate for vaccine application license
Astellas Submits Fezolinetant New Drug Application to U.S. FDA
Published: 2022-06-23 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $15.83 | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: -0.5%
ALPMY | News | $16.205 | twitter stocktwits trandingview |
Manufacturing
| | O: 4.33% H: 0.0% C: -2.44%

fda drug application
CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
CNSP | $0.2611 -1.4% 4.61% | twitter stocktwits trandingview |
Health Technology
| | O: 32.07% H: 1.89% C: -24.85%
RETA | $32.88 5.79% 4.99% | twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 3.99% C: 3.0%

treatment fda ongoing for trial approval berubicin
Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-2059, an Investigational Small Molecule-Based Radiopharmaceutical Targeting Solid Tumors Expressing NTSR1
Published: 2022-06-23 (Crawled : 12:00) - prnewswire.com
FUSN A | $2.75 11.64% | twitter stocktwits trandingview |
Health Technology
| | O: 4.31% H: 5.01% C: -19.47%

fpi-2059 fda clearance for
Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors
Published: 2022-06-22 (Crawled : 00:00) - globenewswire.com
NVS | News | $85.28 0.53% 0.02% | twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%

fda for novartis approval tafinlar
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
Published: 2022-06-22 (Crawled : 21:00) - globenewswire.com
RDUS | News | $10.205 0.94% -0.4% | twitter stocktwits trandingview |
Health Technology
| | O: 12.68% H: 8.17% C: 7.97%

fda elacestrant drug for health application group
U.S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children
Published: 2022-06-22 (Crawled : 17:00) - biospace.com/
MRK | News | $94.41 1.37% 0.27% | twitter stocktwits trandingview |
Health Technology
| | O: 3.24% H: 2.61% C: 1.27%

fda disease for children
VBI Vaccines Receives U.S. FDA Orphan Drug Designation for VBI-1901 for the Treatment of Glioblastoma
Published: 2022-06-22 (Crawled : 12:20) - biospace.com/
VBIV | $0.8496 -7.36% 6.74% | twitter stocktwits trandingview |
Health Technology
| | O: 8.21% H: 26.11% C: 16.65%

vbi-1901 treatment fda designation drug for
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
ANIP | $30.095 4.1% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 6.12% H: 1.73% C: -0.88%

fda approval
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Published: 2022-06-21 (Crawled : 16:00) - biospace.com/
ACER | News A | $1.42 16.39% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -10.23% H: 0.0% C: 0.0%

acer-001 fda drug for application therapeutics review update
Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2022-06-21 (Crawled : 16:00) - biospace.com/
RGLS | $0.225 -6.48% 5.99% | twitter stocktwits trandingview |
Health Technology
| | O: 3.45% H: 0.0% C: 0.0%

rgls8429 treatment fda designation drug disease for kidney therapeutics
AbbVie Submits Supplemental New Drug Application to U.S. FDA for Atogepant (QULIPTA™) to Support Label Expansion for the Preventive Treatment of Migraine
Published: 2022-06-21 (Crawled : 14:00) - biospace.com/
ABBV | News | $153.14 0.53% 0.04% | twitter stocktwits trandingview |
Health Technology
| | O: 1.48% H: 0.0% C: 0.0%

treatment fda expansion drug label for application migraine
Your saved searches
Save your searches and get alerts when important news are released.

Mentioned Today
ABBV | News | $153.14 0.53% 0.04% | twitter stocktwits trandingview |
Health Technology

APPN | News 4 | $54.46 -1.05% 0.38% | twitter stocktwits trandingview |
Technology Services

APPS | News | $17.62 1.62% 5.48% | twitter stocktwits trandingview |
Technology Services

APYX | News | $6.04 1.51% 0.0% | twitter stocktwits trandingview |
Health Technology

BNPQF | News | $50.78 | twitter stocktwits trandingview |
Finance

BNPQY | News | $25.46 | twitter stocktwits trandingview |
Finance and Insurance

BNPZY | News | $ 0% | twitter stocktwits trandingview |
Finance and Insurance

CNXC | News | $147.67 1.63% -0.04% | twitter stocktwits trandingview |
Information

CNXCV | News | $2.27 0% | twitter stocktwits trandingview |
Commercial Services

DMYD | News | $16.21 0% | twitter stocktwits trandingview |
Finance

DMYT | News | $22.76 0% | twitter stocktwits trandingview |
Finance

DRE | News | $56.17 -2.23% 0.0% | twitter stocktwits trandingview |
Finance

EPZM | News | $1.47 54.09% 7.97% | twitter stocktwits trandingview |
Health Technology

ET | News | $10.14 0.4% 0.59% | twitter stocktwits trandingview |
Industrial Services

FBNC | News | $35.7 2.32% 0.0% | twitter stocktwits trandingview |
Finance

FBP | News | $13.52 0.67% 0.0% | twitter stocktwits trandingview |
Finance

FTRP | News | $0.81 1.25% 0.0% | twitter stocktwits trandingview |
Health Care and Social Assistan...

GRRB | News | $30.6 | twitter stocktwits trandingview |
Finance and Insurance

HR | News | $27.23 1.38% 0.0% | twitter stocktwits trandingview |
Finance

HTA | News | $27.7 -0.22% 0.0% | twitter stocktwits trandingview |
Finance

IE | News 0 d new | $ 0% | twitter stocktwits trandingview |
n/a

IONQ | News | $4.83 -5.48% 2.07% | twitter stocktwits trandingview |
Professional, Scientific, and T...

LLY | News 4 | $327.27 0.51% 0.04% | twitter stocktwits trandingview |
Health Technology

LMPX | News | $4.62 0.43% 0.0% | twitter stocktwits trandingview |
Technology Services

NFLX | News | $189.14 -0.9% 0.52% | twitter stocktwits trandingview |
Consumer Services

OBCI | News | $12.86 0.0% | twitter stocktwits trandingview |
Consumer Non-Durables

OMC | News | $64.75 0.23% 0.0% | twitter stocktwits trandingview |
Commercial Services

ONEW | News | $35.25 3.68% 0.0% | twitter stocktwits trandingview |
Retail Trade

OSCR | News | $4.55 2.94% 0.0% | twitter stocktwits trandingview |

PACB | News | $5.3 -5.53% -1.78% | twitter stocktwits trandingview |
Health Technology

PEGA | News | $51.68 -1.97% 0.0% | twitter stocktwits trandingview |
Technology Services

PFHC | News | $19.75 6.35% -4.95% | twitter stocktwits trandingview |

PLD | News | $120.21 -1.94% 0.54% | twitter stocktwits trandingview |
Finance

PSORF | News | $9.55 0% | twitter stocktwits trandingview |
Consumer Services

RDUS | News | $10.205 0.94% -0.4% | twitter stocktwits trandingview |
Health Technology

SNY | News | $52.62 -1.5% -0.41% | twitter stocktwits trandingview |
Health Technology

SNYNF | News | $104.5 | twitter stocktwits trandingview |
Health Technology

SPRO | News | $0.931 -0.96% 3.19% | twitter stocktwits trandingview |
Health Technology

SREV | News | $1.45 -2.76% | twitter stocktwits trandingview |
Technology Services

TGTX | News | $4.34 -1.36% -2.05% | twitter stocktwits trandingview |
Health Technology

TUP | News 4 | $7.16 1.42% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

USAK | News | $30.85 -0.48% -0.39% | twitter stocktwits trandingview |
Transportation

USWS | News | $0.995 4.08% -0.63% | twitter stocktwits trandingview |
Finance

VRCA | News | $2.195 4.03% 10.43% | twitter stocktwits trandingview |
Health Technology

WWE | News | $61.0 0.63% 0.0% | twitter stocktwits trandingview |
Consumer Services

XRAY | News | $36.74 -0.05% 0.0% | twitter stocktwits trandingview |
Health Technology

ZEN | News | $74.65 0.65% -0.07% | twitter stocktwits trandingview |
Technology Services